Chatterjee Subroto, Pandey Ambarish
Lipid Research Artherosclerosis Unit, Department of Pediatrics, Suit 312, 550 North Broadway, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Biochim Biophys Acta. 2008 Mar;1780(3):370-82. doi: 10.1016/j.bbagen.2007.08.010. Epub 2007 Aug 25.
Although lactosylceramide (LacCer) plays a pivotal role in the biosynthesis of nearly all the major glycosphingolipids, its function in regulating cellular function has begun to emerge only recently. Our current opinion is that several physiologically critical molecules such as modified/oxidized LDL, growth factors, pro-inflammatory cytokines and fluid shear stress converge upon and activate lactosylceramide synthase to generate LacCer. In turn, LacCer activates an "oxygen-sensitive" signaling pathway involving superoxides, nitric oxide, p21 Ras GTP loading, kinase cascade, PI3kinase/Akt activation, nuclear factor up-regulation ultimately contributing to phenotypic changes such as cell proliferation, adhesion, migration and angiogenesis. Since dys-regulation of such phenotypic changes constitute a hallmark in several diseases of the cardiovascular system, proliferative disorders such as cancer, polycystic kidney disease and inflammatory diseases, LacCer synthase and LacCer provide novel targets for the development of therapeutics aimed at these health conditions.
尽管乳糖基神经酰胺(LacCer)在几乎所有主要糖鞘脂的生物合成中起着关键作用,但其在调节细胞功能方面的作用直到最近才开始显现。我们目前的观点是,一些生理上至关重要的分子,如修饰/氧化的低密度脂蛋白、生长因子、促炎细胞因子和流体剪切应力,会作用于并激活乳糖基神经酰胺合酶以生成LacCer。反过来,LacCer会激活一条“氧敏感”信号通路,该通路涉及超氧化物、一氧化氮、p21 Ras GTP负载、激酶级联反应、PI3激酶/Akt激活、核因子上调,最终导致细胞增殖、黏附、迁移和血管生成等表型变化。由于这些表型变化的失调是心血管系统的几种疾病、癌症等增殖性疾病、多囊肾病和炎症性疾病的一个标志,乳糖基神经酰胺合酶和LacCer为针对这些健康状况开发治疗药物提供了新的靶点。